737
Hello, We would like to know if PAAB would accept the following tool: A desk-calendar for HCPs to use as a counselling tool for when they are scheduling the next dose of a vaccine. It would also feature facts about the disease and best practice tips. Thank you.
-
Voir réponse [+]
Although the concept itself of creating a desk-calendar which can be used to council patients is possible, here are a few suggestions to try to ensure a smooth review process. First and foremost, this is HCP advertising and as such is subject to PAAB review. As the piece will be viewed by both HCPs and patients, it must be clear what information is intended for which audience. Finally, based on the question, it sounds like this will be a branded piece. Be cautious that the disease information does not go beyond the products TMA (i.e. it is on-label).
736
We're developing a pull-up banner and the amount of Fair Balance is not allowing for space for the message. Could we apply the principles allowed for journal ads? Specifically, have medium fair balance on the pull-up banner and direct the reader to a handout adjacent to the panel with the full fair balance?
-
Voir réponse [+]
No. The specifications for using middle level fair balance to link to highest level fair balance, are that it is within the same tool (e.g. Print tool X cannot direct the HCP to the separate print tool Y for highest level fair balance) AND in the same medium. As in a journal ad, this would mean later in the same journal; the highest level fair balance should appear within the pull-up banner somewhere. If the space required for fair balance is not sufficient, we suggest revising the nature of the claims to require only middle or lowest level fair balance.
735
Hello, If we want to do a video about the Mode of action of a drug, apart from the PM, what other references can we use?
-
Voir réponse [+]
Authoritative sources such as published medical text books, can be considered as additional support for the content within the TMA. The content should not go above or beyond the specifics of the TMA.
734
In a company sponsored presentation, can a physician talk about off-label for another drug (not the sponsors drug) e.g. "In my practice I use Drug X to treat nausea", but Drug X is not indicated for nausea.
-
Voir réponse [+]
No. All advertising content should be consistent with and within the limitations of the products respective product monographs. Off-label uses should not be discussed for any products.
733
Is it voluntary to get promotional materials approved and simply acts as a benefit to the product or is it this process mandatory?
732
Is this "Ask PAAB" still active? We have submitted queries 4-weeks ago and did not see any responses? Could you please provide an update?
731
Is the PAAB logo required to appear on HCP advertising or patient information approved by PAAB.
-
Voir réponse [+]
Yes. This also applies to editorials and corporate ads. Inclusion in RMTs is not permitted at all as these tools have not been reviewed for compliance with the Code. Health Canada has simply requested that PAAB review these tools to ensure they are non-promotional.
730
Hi Patrick, I have a question related to providing PAAB training. I remember few years ago you came to our company and you provided training. There have been many changes since then and I was wondering if you are still providing similar training. What is the cost associated with this type of activity?
-
Voir réponse [+]
Yes, we do still provide training as part of our ongoing commitment to help industry better understand the regulations. There are a few options. We provide in-house training, at a location of your choice. This is a 2 hour training session and the cost is $1000 plus travel expenses. We also offer national workshops once a year in Toronto and Montreal, which are full day sessions. This information can be found on the PAAB website under “About – Fee Schedule”.
729
Can you please confirm that use of a drug name along with its pharmacologic classification (eg. 'diuretic') is exempt from PAAB review? The therapeutic classification (eg. 'antihypertensive') would not be included, as this alludes to therapeutic use.
728
Hi Patrick - I've read the 2019 Client Survey report on the PAAB website. Is there a plan to disseminate this more broadly, and what actions is the PAAB taking with regards to any of the specific survey results? Thank you.
-
Voir réponse [+]
The 2019 Client Insight research has been posted to the PAAB website and is available for access by the broader public. The PAAB is constantly working through the results to try and update processes and procedures. We will be looking to industry and the community to help shape new endeavours. Please follow us and stay tuned to the PAAB website, LinkedIn and Twitter (@ThePAAB) for opportunities to join new committees to help shape change.
